RaySearch Laboratories Unveils Cutting-Edge Particle Therapy Solutions
RaySearch Laboratories AB (publ) is gearing up to exhibit groundbreaking software innovations at the upcoming PTCOG 63 event. The conference will take place soon, showcasing the company's commitment to advancing particle therapy. At booth #08, attendees can expect to see firsthand the latest advancements that are shaping the future of cancer treatment.
RaySearch's product line is at the forefront of transforming intricate treatment systems into intelligent and adaptive solutions in oncology. The RayStation®, RayCare®, RayIntelligence®, and RayCommand® offerings reflect a commitment to enhancing the efficiency and safety of cancer care.
Significant Features in Particle Therapy
One of the noteworthy highlights featured in this presentation is the clinical application of proton arc therapy. This method stands out for its ability to enhance dose conformity while sparing surrounding healthy organs. Another key element is the Monte Carlo dose engine, which leverages ultra-fast, GPU-based computation to optimize treatment planning without compromising accuracy. The introduction of robust optimization further ensures integrated uncertainty management, providing comprehensive evaluation of treatment plans.
The upright treatment planning capability ranks also high among RaySearch's innovations, greatly supporting workflows for fixed beamline treatments. This particular feature emphasizes not only improved patient comfort but also enhances facility design.
Latest Innovations in RaySearch Systems
In addition to showcasing RayStation, which is continually evolving, RaySearch will highlight its high-speed adaptive replanning capabilities. This includes the expansion of AI-driven image segmentation, making strides in automated planning utilizing both machine learning techniques and conventional algorithms. Among the exciting developments is the introduction of three new models for deep learning planning, underscoring RaySearch's innovative approach in the realm of treatment planning.
The latest automated planning algorithm, known as ECHO, will also be demonstrated. This sophisticated tool, which was originally developed by Memorial Sloan Kettering Cancer Center, has been seamlessly integrated into RayStation, emphasizing its potential to revolutionize planning efficiency.
Enhancements in Oncology Workflows
RayCare will exemplify a transformative approach to oncology workflows, orchestrating every step in the process of cancer treatment. This system boasts essential features like active oncology workflows, high-level automation, and advanced treatment course management. By facilitating tight integration with RayStation and treatment machines, RayCare establishes a new standard focusing on efficiency and patient-centered care.
Moreover, RayIntelligence, which functions as a cloud-based oncology analytics system, will be showcased. This platform enables cancer clinics to merge fragmented data into streamlined, decision-driving insights. The intuitive data dashboards offer vital overviews of treatment planning and clinic performance, promoting a comprehensive understanding of clinical operations.
Additionally, on display will be RayCommand, which acts as a treatment control system connecting planning with existing information systems, and µ-RayStation, specifically designed for research in small animal irradiation.
Join Us at PTCOG 63
We invite all conference attendees to visit us at booth #08 and explore how RaySearch is paving the way for the future of particle therapy. Our innovative solutions are dedicated to improving cancer care, providing practitioners with the tools needed for transformative patient outcomes.
About RaySearch Laboratories
RaySearch Laboratories AB (publ) specializes in developing groundbreaking software solutions aimed at enhancing cancer treatment. Their flagship product, RayStation®, is a highly flexible treatment planning system recognized globally. Furthermore, the RayCare® oncology information system works harmoniously alongside RayStation to deliver a seamless treatment experience.
To date, RaySearch's software solutions have been adopted by over 1,100 clinics across 47 countries, marking the company as an industry leader since its inception in 2000. The organization, initially launched as a spin-off from the Karolinska Institute in Stockholm, has been listed on Nasdaq Stockholm since 2003.
Frequently Asked Questions
What innovations will RaySearch highlight at PTCOG 63?
RaySearch will showcase advancements like proton arc therapy, a Monte Carlo dose engine, and state-of-the-art automated planning technologies.
What are the benefits of RayStation's updated features?
RayStation provides improved adaptive replanning, better AI-driven image segmentation, and the integration of new deep learning planning models.
How does RayCare enhance oncology workflow?
RayCare enhances workflow by automating key processes, managing treatment courses, and improving coordination among different systems.
What is RayIntelligence?
RayIntelligence is a cloud-based analytics system that integrates data to support decision-making in cancer treatment, providing actionable insights.
When and where is PTCOG 63 being held?
PTCOG 63 will be held soon, where RaySearch will exhibit at booth #08, emphasizing innovations in particle therapy.
